Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
bispecific T-cell engager
|
| gptkbp:clinicalTrialPhase |
Phase 1
NCT03319940 |
| gptkbp:developedBy |
gptkb:Amgen
|
| https://www.w3.org/2000/01/rdf-schema#label |
AMG 757
|
| gptkbp:indication |
Small Cell Lung Cancer
|
| gptkbp:macromoleculeType |
bispecific antibody
|
| gptkbp:mechanismOfAction |
redirects T cells to kill DLL3-expressing tumor cells
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:DLL3
|
| gptkbp:bfsParent |
gptkb:Tarlatamab
|
| gptkbp:bfsLayer |
7
|